Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
PR Newswire•20/10/2026•08:00 ET
0
Key Highlights
- ➤Evogene (EVGN) joins U.S. East Coast AI drug discovery roadshow November 2-5, 2026
- ➤Roadshow connects Israeli AI biotech companies with U.S. investors and pharmaceutical firms
- ➤CEO Ofer Haviv will present ChemPass AI™ generative small-molecule discovery platform
- ➤Evogene seeks strategic relationships and collaboration opportunities across U.S. pharmaceutical markets
Expert Statements
Ofer Haviv, President and Chief Executive Officer of Evogene
“ChemPass AI™, a proprietary generative AI platform for discovering and optimizing novel small molecules”
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL PR Newswire
The roadshow will connect leading Israeli AI-driven drug discovery and biotechnology companies with U.S. investors, pharmaceutical companies, and potential strategic partners
Get started
Create a free account to read the full story.